Core Viewpoint - Nu Skin Enterprises, Inc. is facing significant challenges due to macroeconomic pressures, a sluggish direct selling environment, and adverse foreign currency fluctuations, leading to a bleak outlook for 2024 [1][2][4] Financial Performance - In Q2 2024, Nu Skin's revenues fell 12.2% year over year to 1.73 billion and 1.85 in 2023 [4] - For Q3 2024, expected revenues are between 465 million, indicating a decline of 14% to 7% year over year [4] Analyst Sentiment - The Zacks Consensus Estimate for EPS has been revised downward by 58.3% for the current quarter and 29.1% for the fiscal year, indicating significant year-over-year declines [5] Stock Performance - Nu Skin's shares have decreased by 44.9% over the past three months, underperforming the industry average decline of 24.9% [6] - The stock is trading below its 50 and 200-day moving averages, suggesting potential weakness in momentum [6] Strategic Initiatives - The company is implementing strategic initiatives to revitalize its market presence, focusing on new product launches and the Rhyz business [7] - However, these efforts may take time to yield significant results amid ongoing macroeconomic and industry-specific challenges [7]
NUS Stock Hurt by Customer Acquisition Challenges: How to Play Ahead?